Filter posts

BIO Investor Forum Company Snapshot: Protagonist Therapeutics

In our final Investor Forum Company Snapshot, we’ve profiled one of the Discovery Companies who …

BIO Investor Forum Company Snapshot: Immune Design

In the third installment of the Investor Forum Company Snapshots, hear from Immune Design Corp. …

Perspective on Market Valuation for Biotech Drug Developers

Of the 300 publicly traded U.S. biotechs, 219 (73%) are developing drugs. The other 27% …

Technology Transfer Symposium in San Francisco

In the midst of turbulent economic times, and at a moment when the U.S. is …

BIO Investor Forum Company Snapshot: Syndax Pharmaceuticals

Next up in our Company Snapshot segment for the BIO Investor Forum is another presenting …

BIO Investor Forum Company Snapshot: GlobeImmune, Inc.

The BIO Investor Forum will be here before we know it, and we wanted to …

Fall Preview: Business Development Events

Now that the Business Forum and International Convention are behind us, our Business Development department …

State of the Industry - From BIO Investor Forum 2010

Here is our slide deck from the 9th annual BIO Investor Forum in San Francisco: …

The booming H1N1 vaccine market

The vaccine market is booming – and biotech companies are just one of the beneficiaries.  …

Perspectives on today's IPO candidates

Some speculation is coming back into the sector but most movement in public markets is …